| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7803095 | European Journal of Medicinal Chemistry | 2011 | 8 Pages |
Abstract
âºTyrosine kinase inhibitors are useful in treatment of cancer diseases. âºThe most active in vivo compounds show multi-kinase inhibitory potency. âºQSAR models could help in multi-target novel compound design.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Giovanni Marzaro, Adriana Chilin, Adriano Guiotto, Eugenio Uriarte, Paola Brun, Ignazio Castagliuolo, Francesca Tonus, Humberto González-DÃaz,